We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

5 hedge funds and large institutions have $100K invested in Revelation Biosciences, Inc. Unit in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding

Funds holding: 1 → 5 (+4)

355% more capital invested

Capital invested by funds: $22K → $100K (+$78K)

Holders
5
Holders Change
+4
Holders Change %
+400%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$123K
2
Walleye Trading
Walleye Trading
New York
+$71.8K
3
TSS
Two Sigma Securities
New York
+$10.5K
4
VF
Virtu Financial
New York
+$7.61K
5
UBS Group
UBS Group
Switzerland
+$2.24K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$57K +$123K +177,428 New
Walleye Trading
2
Walleye Trading
New York
$33K +$71.8K +104,022 New
TSS
3
Two Sigma Securities
New York
$5K +$10.5K +15,215 New
VF
4
Virtu Financial
New York
$4K +$7.61K +11,023 New
UBS Group
5
UBS Group
Switzerland
$1K +$2.24K +3,250 New

REVBU Hedge Fund Activity: Q3 2022 in Review

5 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q3 2022, worth a combined $100K — up 355% from $22K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new REVBU positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Walleye Capital, opening a new position worth an estimated $123K.

  • 5 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q3 2022, up from 1 in Q2 2022.
  • Funds reported $100K of Revelation Biosciences, Inc. Unit stock for Q3 2022, up 355% quarter-over-quarter.
  • 5 funds opened new Revelation Biosciences, Inc. Unit positions in Q3 2022 and 0 closed out, a net change of +5 holders.
  • The largest Revelation Biosciences, Inc. Unit buyer in Q3 2022 was Walleye Capital, an estimated $123K added.

Based on aggregated 13F filings for Q3 2022.